enVVeno Medical (NVNO) Change in Acquisitions & Divestments (2022 - 2026)
enVVeno Medical's (NVNO) quarterly Change in Acquisitions & Divestments came in at $25.0 million in Q1 2026, up 77.71% year-on-year from $14.1 million in Q1 2025, and up 6.44% quarter-over-quarter from $23.5 million in Q4 2025.
enVVeno Medical (NVNO) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
enVVeno Medical's Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $25.0 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 77.71% year-over-year to $25.0 million in Q1 2026; TTM through Mar 2026 was $72.8 million, a 35.67% increase from a year earlier, with the FY2025 full-year figure at $61.9 million, up 8.68% from the prior year.
- Change in Acquisitions & Divestments improved to $25.0 million in Q1 2026 per NVNO's latest filing, from $23.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $25.0 million in Q1 2026 and bottomed at $10.1 million in Q4 2023.
- The 5-year median for Change in Acquisitions & Divestments is $13.6 million (2023), against an average of $14.6 million.
- Biggest YoY gain for Change in Acquisitions & Divestments was 111.79% in 2025; the steepest drop was 22.7% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $11.4 million in 2022, then dropped by 11.66% to $10.1 million in 2023, then increased by 9.81% to $11.1 million in 2024, then surged by 111.79% to $23.5 million in 2025, then advanced by 6.44% to $25.0 million in 2026.
- Per Business Quant, the three latest NVNO Change in Acquisitions & Divestments figures stand at $25.0 million (Q1 2026), $23.5 million (Q4 2025), and $13.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | enVVeno Medical | 6.85 Mn | 6.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.01 Mn |
| Mar 31, 2026 | 25.01 Mn |
| Dec 31, 2025 | 23.50 Mn |
| Dec 31, 2025 | 23.50 Mn |
| Sep 30, 2025 | 13.55 Mn |
| Sep 30, 2025 | 13.55 Mn |
| Jun 30, 2025 | 10.76 Mn |
| Jun 30, 2025 | 10.76 Mn |
| Mar 31, 2025 | 14.08 Mn |
| Mar 31, 2025 | 14.08 Mn |
| Dec 31, 2024 | 11.10 Mn |
| Dec 31, 2024 | 11.10 Mn |
| Sep 30, 2024 | 14.58 Mn |
| Sep 30, 2024 | 14.58 Mn |
| Jun 30, 2024 | 13.92 Mn |
| Jun 30, 2024 | 13.92 Mn |
| Mar 31, 2024 | 17.34 Mn |
| Mar 31, 2024 | 17.34 Mn |
| Dec 31, 2023 | 10.10 Mn |
| Dec 31, 2023 | 10.10 Mn |